Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,130.00
(
0.48%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
100.55
(
-0.10%
)
Bitcoin
73,765.10
(
-0.24%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: genisi post# 77266

Tuesday, 05/05/2009 6:10:20 PM

Tuesday, May 05, 2009 6:10:20 PM

Post# of 257253
Re: Gene Test for Dosage of Warfarin Is Rebuffed

This decision is somewhat surprising but is close to inconsequential from a medical standpoint because warfarin will likely be gone from the US market in the next few years. (Warfarin is rarely used outside the US even today.)

drbio (who is long ARYX) probably disagrees.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now